Search research articles
Contact Us
Filters
Showing results (41-50 of 79) with videos related to
Page
of 8
Sort By:
Substance Abuse
|
February 22, 2021
Understanding barriers to treatment among individuals not engaged in treatment who misuse opioids: A structural equation modeling approach
Patricia Cavazos-Rehg, Christine Xu, Melissa J Krauss, et al.
Journal of Clinical Pharmacology
|
March 19, 2025
Population Pharmacokinetics and Exposure-Response Analyses of Sarilumab in Patients with Polymyalgia Rheumatica
Christine Xu, William S Denney, Ying Liu, et al.
Cancer Chemotherapy and Pharmacology
|
June 16, 2020
Assessment of effects of repeated oral doses of fedratinib on inhibition of cytochrome P450 activities in patients with solid tumors using a cocktail approach
Ken Ogasawara, Patricia M LoRusso, Anthony J Olszanski, et al.
Cancer Chemotherapy and Pharmacology
|
July 22, 2009
Serum concentrations of pegylated interferon alpha-2b in patients with resected stage III melanoma receiving adjuvant pegylated interferon alpha-2b in a randomized phase III trial (EORTC 18991)
Alexander M M Eggermont, Marna G Bouwhuis, Wim H Kruit, et al.
Ophthalmology. Glaucoma
|
October 17, 2022
Combined Model of OCT Angiography and Structural OCT Parameters to Predict Paracentral Visual Field Loss in Primary Open-Angle Glaucoma
Christine Xu, Chhavi Saini, Mengyu Wang, et al.
Clinical Pharmacology in Drug Development
|
June 23, 2021
Base and Covariate Population Pharmacokinetic Analyses of Dupilumab in Adolescents and Children ≥6 to <12 Years of Age Using Phase 3 Data
Pavel Kovalenko, Mohamed A Kamal, John D Davis, et al.
Modern Rheumatology
|
April 21, 2022
Pharmacokinetics, pharmacodynamics, and safety of single-dose subcutaneous sarilumab with or without methotrexate in Japanese patients with rheumatoid arthritis: Two single-dose studies
Tomonori Ishii, Yukio Sato, Yasuhiko Munakata, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 30, 2014
Tildrakizumab, a novel anti-IL-23 monoclonal antibody, is unaffected by ethnic variability in Caucasian, Chinese, and Japanese subjects
Anthe Zandvliet, Shirley Glasgow, Ann Horowitz, et al.
AIDS Care
|
June 20, 2020
The impact of discomfort with HIV status and hopelessness on depressive symptoms among adolescents living with HIV in Uganda
Patricia Cavazos-Rehg, Christine Xu, Jacob Borodovsky, et al.
Clinical Pharmacology in Drug Development
|
March 12, 2022
Pharmacokinetics of Subcutaneous Dupilumab Injection With an Autoinjector Device or Prefilled Syringe
Yehuda Z Cohen, Xiaojia Zhang, Binfeng Xia, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 79) with videos related to
Sort By:
Page
of 8
Substance Abuse
|
February 22, 2021
Understanding barriers to treatment among individuals not engaged in treatment who misuse opioids: A structural equation modeling approach
Patricia Cavazos-Rehg, Christine Xu, Melissa J Krauss, et al.
Journal of Clinical Pharmacology
|
March 19, 2025
Population Pharmacokinetics and Exposure-Response Analyses of Sarilumab in Patients with Polymyalgia Rheumatica
Christine Xu, William S Denney, Ying Liu, et al.
Cancer Chemotherapy and Pharmacology
|
June 16, 2020
Assessment of effects of repeated oral doses of fedratinib on inhibition of cytochrome P450 activities in patients with solid tumors using a cocktail approach
Ken Ogasawara, Patricia M LoRusso, Anthony J Olszanski, et al.
Cancer Chemotherapy and Pharmacology
|
July 22, 2009
Serum concentrations of pegylated interferon alpha-2b in patients with resected stage III melanoma receiving adjuvant pegylated interferon alpha-2b in a randomized phase III trial (EORTC 18991)
Alexander M M Eggermont, Marna G Bouwhuis, Wim H Kruit, et al.
Ophthalmology. Glaucoma
|
October 17, 2022
Combined Model of OCT Angiography and Structural OCT Parameters to Predict Paracentral Visual Field Loss in Primary Open-Angle Glaucoma
Christine Xu, Chhavi Saini, Mengyu Wang, et al.
Clinical Pharmacology in Drug Development
|
June 23, 2021
Base and Covariate Population Pharmacokinetic Analyses of Dupilumab in Adolescents and Children ≥6 to <12 Years of Age Using Phase 3 Data
Pavel Kovalenko, Mohamed A Kamal, John D Davis, et al.
Modern Rheumatology
|
April 21, 2022
Pharmacokinetics, pharmacodynamics, and safety of single-dose subcutaneous sarilumab with or without methotrexate in Japanese patients with rheumatoid arthritis: Two single-dose studies
Tomonori Ishii, Yukio Sato, Yasuhiko Munakata, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
December 30, 2014
Tildrakizumab, a novel anti-IL-23 monoclonal antibody, is unaffected by ethnic variability in Caucasian, Chinese, and Japanese subjects
Anthe Zandvliet, Shirley Glasgow, Ann Horowitz, et al.
AIDS Care
|
June 20, 2020
The impact of discomfort with HIV status and hopelessness on depressive symptoms among adolescents living with HIV in Uganda
Patricia Cavazos-Rehg, Christine Xu, Jacob Borodovsky, et al.
Clinical Pharmacology in Drug Development
|
March 12, 2022
Pharmacokinetics of Subcutaneous Dupilumab Injection With an Autoinjector Device or Prefilled Syringe
Yehuda Z Cohen, Xiaojia Zhang, Binfeng Xia, et al.
Page
of 8